Molecular farming on the rise – GMO regulators still walking a tightrope

Recent increases in EU commercial and academic activities in molecular farming, and the proximity to market-stage of the first plant-made pharmaceuticals, represent a call to action for EU regulators. Drawing on the North American debate on molecular farming, it will be argued that both the rational...

Full description

Saved in:
Bibliographic Details
Published in:Trends in biotechnology (Regular ed.) 2007-02, Vol.25 (2), p.74-82
Main Author: Spok, A
Format: Article
Language:English
Subjects:
Biological and medical sciences
biopharmaceuticals
Biotechnology
Biotechnology - standards
Biotechnology - trends
Cell culture
Competent authority
Consumer Product Safety - legislation & jurisprudence
Crops
Drug Industry - legislation & jurisprudence
Environmentalists
European Union
Farming
Food
Fundamental and applied biological sciences. Psychology
Genetically altered foods
Internal Medicine
laws and regulations
literature reviews
molecular farming
Pharmaceutical Preparations
Plant Preparations - adverse effects
Plant Preparations - isolation & purification
Plants, Genetically Modified
Public Policy
R&D
Recombinant Proteins - biosynthesis
Regulation of financial institutions
Regulatory approval
Research & development
Risk assessment
Risk Factors
Seeds
transgenic plants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent increases in EU commercial and academic activities in molecular farming, and the proximity to market-stage of the first plant-made pharmaceuticals, represent a call to action for EU regulators. Drawing on the North American debate on molecular farming, it will be argued that both the rationale and the risks of molecular farming will differ significantly from those of first generation GM crops. Based on these differences, the suitability of the existing regulatory frameworks, which were developed in response to the arrival of earlier products, is discussed, and specific options for adapting the already complex EU regulatory system to cater for molecular farming are examined.
ISSN:0167-7799
1879-3096
DOI:10.1016/j.tibtech.2006.12.003